Revenue segments as reported by the company.

Premiums

Product revenue

Administrative fees and other revenue

Net investment income

Net gains on financial instruments

Gain on sale of business

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit expense

Selling, general and administrative

Interest expense

Amortization of other intangible assets

Loss on extinguishment of debt

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Elevance Health Inc

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The firm supports consumers, families, and communities across the entire care journey, connecting them to the care, support, and resources they need to lead healthier lives. It offers health plans and clinical, behavioral, pharmacy, and complex-care solutions which promote whole health. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Elevance Health reports robust Q4 earnings, eyes margin optimization

Elevance Health's strong Q4 2022 performance, strategic acquisitions, and focus on margin optimization position the company for continued growth. With a clear outlook for 2023, emphasizing membership expansion and margin recovery, the company is poised for success. Challenges in optimizing margins and managing cost structures are balanced by growth opportunities and strategic initiatives.

Elevance Health reports robust Q1 growth and innovation in healthcare

Elevance Health Inc demonstrated strong financial performance and growth in Q1 2023, driven by increased membership and solid operating results.
The company's focus on advocacy, innovation, and sustainability, along with strategic investments in healthcare capabilities, positions it for continued success.
While facing challenges in cost management and strategic partnerships, Elevance Health is well-positioned to capitalize on opportunities in specialty care and value-based models.
Overall, Elevance Health's commitment to whole health, innovation, and value-based care sets a positive trajectory for future growth and industry leadership.

Elevance Health Inc posts robust Q2 earnings, eyes value-based care

Elevance Health Inc reported strong Q2 earnings, raised adjusted EPS outlook to over $32.85 for the year, and emphasized a focus on value-based care and digital solutions. While facing margin pressure in Carelon, the company remains confident in its strategy execution and performance for 2023 and beyond.

Elevance Health excels in Q3, eyes growth through strategic actions

Elevance Health's Q3 performance was strong, with a focus on operational efficiency and strategic investments. Challenges in Medicare ratings were addressed through proactive measures, while opportunities lie in growth acceleration and strategic partnerships. The company remains on track to achieve its long-term growth targets.

Elevance Health Inc surpasses earnings expectations, eyes growth opportunities

Elevance Health Inc's strong financial performance in Q4 2023 and full-year results, coupled with strategic initiatives in expanding capabilities and enhancing operational efficiency, position the company for continued success. Challenges in commercial repricing and Medicaid dynamics are being addressed, while opportunities in Medicare Advantage and strategic investments offer avenues for growth.

Elevance Health posts robust Q1 earnings, eyes strategic growth

Elevance Health demonstrated strong financial performance in Q1, with revenue growth and margin expansion in key segments.
While facing challenges like potential Medicare rate cuts, the company is leveraging partnerships and acquisitions for growth.
Opportunities lie in expanding service offerings, geographic footprint, and optimizing Medicaid margins for long-term sustainability.

Elevance Health Inc reports robust earnings growth and strategic wins

Elevance Health's Q2 performance reflects strong earnings growth and reaffirmed guidance, driven by solid segment performance and new business wins.
The company's strengths lie in its high Medicare rating, robust revenue growth in services, and strategic focus on value creation.
Challenges include sustaining growth momentum, managing funding cuts, and effectively integrating recent acquisitions for long-term success.
Opportunities exist in accelerating capabilities, expanding market share, optimizing operations, and leveraging workplace recognition for talent attraction and innovation.

Elevance Health faces Medicaid challenges, sees growth in AI investments

Elevance Health's Q3 earnings were impacted by elevated medical costs in Medicaid, leading to a reduction in full-year outlook. Despite challenges in the Medicaid business, the company's Medicare Advantage and Commercial businesses are performing well. Investments in AI and expansion of Carelon Services present growth opportunities.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health showcased strong financial growth in Q4 and the full year of 2023, highlighting increased revenues and earnings per share. Technical analysis indicates a bullish trend, with the stock price currently preparing for a potential rally. A rounding bottom pattern within the strong uptrend suggests a strong price surge.

Elevance Heath: Financial Growth And Technical Strength Indicate A Buy

Bank of America

Cigna

Domino's Pizza

Global Payments

Mastercard

Microchip Technology

Monolithic Power Systems

MSCI

NIKE

Old Dominion Freight Line

Rollins

Sirius XM Holdings Inc

UnitedHealth Group

Zoetis

The SPDR S&P 500 ETF Trust had a 5.22% return in February, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares.

My Top 15 High Growth Dividend Stocks For March 2024

Analog Devices

AMETEK

Blackrock Inc

Canadian National Railway Company

Eversource Energy

Exponent

Diamondback Energy

Genpact

Home Depot

Jack Henry & Associates

Kimberly-Clark

Knight-Swift Transportation Holdings

L3Harris

Mosaic

EnPro Industries

Northrim BanCorp

Novartis

Public Service Enterprise Group

Perrigo

Reliance Steel & Aluminum

Schwab US Dividend Equity ETF

Schneider National

A new list of 27 new dividend increases, including King Kimberly-Clark and three other champions.

27 Upcoming Dividend Increases Including A Dividend King

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?

Why Is Elevance Health (ELV) Up 6.6% Since Last Earnings Report?

Elevance Health (ELV) closed at $512.17 in the latest trading session, marking a +0.55% move from the prior day.

Here's Why Elevance Health (ELV) Gained But Lagged the Market Today

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the Cowen 44th Annual Health Care Conference in Boston on March 5, at 2:50 p.m. Eastern Standard Time (EST). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the webcast here. For those unable to listen to the live webcast, a replay will be availabl.

Elevance Health Announces Appearance at the Cowen 44th Annual Health Care Conference

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Barclays 26th Annual Global Healthcare Conference in Miami, on March 14 at 9:30 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here. For those unable to listen to the live webcast, a replay will be availa.

Elevance Health Announces Appearance at Barclays 26th Annual Global Healthcare Conference

AGCO

Assurant

Today, we are looking at some dividend contenders and then applying further criteria based on growth, payout ratio and valuation to find 25 names worth exploring further. We then give three companies a deeper look due to trading below their fair value estimates or looking like a relatively attractive prospect.

3 Dividend Contenders To Grow Your Income

Apollo Medical Hlds

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and Apollo Medical Holdings, Inc. (AMEH). But which of these two companies is the best option for those looking for undervalued stocks?

ELV or AMEH: Which Is the Better Value Stock Right Now?

Here is how Elevance Health (ELV) and HCA Healthcare (HCA) have performed compared to their sector so far this year.

Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year?

Humana

Universal Display

SPDR S&P 500 ETF Trust

Thermo Fisher Scientific

Tractor Supply

In this series, I rank a selection of dividend growth stocks in Dividend Radar and present the ten top-ranked stocks for consideration. To rank stocks, I do a quality assessment and sort stocks by quality scores, breaking ties with additional metrics. This month, I'm presenting candidates with high earnings, revenue, and dividend growth rates trading at favorable valuations. Additionally, the stocks all have 5-year trailing total returns above 10%.

10 Dividend Growth Stocks: February 2024

Cencora Inc

HealthEquity

The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and HQY are set to gain the most.

3 Medical Services Stocks to Buy Amid Industry Headwinds

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces the expansion of its community resiliency and disaster relief grants through an additional $1.2 million in awards. Each grant supports organizations focused on utilizing available resources to respond to, withstand, and recover from adverse situations as well as disaster preparedness, response, and recovery efforts. In 2023, the United States experienced 28 weather and climate di.

Elevance Health Foundation Strengthens Commitment to Community Resiliency, Disaster Relief Through New Grants

INDIANAPOLIS--(BUSINESS WIRE)-- #AmericasMostJUST--Today JUST Capital along with CNBC released its annual JUST 100 list as part of its 2024 Rankings of America's Most JUST Companies. Elevance Health (NYSE: ELV) ranked #8 overall and was recognized for the 6th consecutive year for its commitment to serving its workers, customers, communities, the environment, and shareholders. The JUST 100 are determined by scoring performance across a full range social impact and sustainability criteria and comparing companies hea.

Elevance Health Named in Top 10 of America's Most JUST Companies by JUST Capital and CNBC

Allegion

EOG Resources

MarketAxess Holdings

SS&C Technologies Hlds

Visa

Vanguard Dividend Appreciation ETF

The SPDR S&P 500 ETF Trust had a 1.59% return in January, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares. The top 15 dividend growth stocks for February 2024 offer an average dividend yield of 1.43% and appear to be about 29% undervalued based on dividend yield theory.

Top 15 High Growth Dividend Stocks For February 2024

Avantor Inc.

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?

ELV vs. AVTR: Which Stock Is the Better Value Option?

Here is how Elevance Health (ELV) and McKesson (MCK) have performed compared to their sector so far this year.

Is Elevance Health, Inc. (ELV) Outperforming Other Medical Stocks This Year?

Elevance Health reported Q4 earnings that beat expectations for both EPS and revenue. The company exceeded its 2023 guidance but disappointed with its 2024 guidance, predicting flat to low single-digit revenue growth.

Elevance Health Q4: Undervalued Despite Risks To Core Business

Elevance Health rewarded shareholders with a 10.1% hike in its quarterly dividend per share. The managed care company's operating revenue and adjusted diluted EPS climbed in the fourth quarter. Elevance Health enjoys an A credit rating from S&P on a stable outlook.

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

News for Elevance Health Inc Stock (ELV)